Craving is associated with amygdala volumes in adolescent marijuana users during abstinence

American Journal of Drug and Alcohol Abuse

Volumn 41, Issue 2, 2015, Pages 127-132

  Padula, Claudia B ^a   McQueeny, Tim ^b   Lisdahl, Krista M ^c   Price, Jenessa S ^d   Tapert, Susan F ^e  

^a STANFORD UNIVERSITY   (United States)

^b UNIVERSITY OF CINCINNATI   (United States)

^c UNIVERSITY OF WISCONSIN MILWAUKEE   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Adolescence; Amygdala; Craving; Marijuana; Withdrawal

Indexed keywords

CANNABIS;

ADOLESCENT; ADULT; AMYGDALOID NUCLEUS; ARTICLE; BRAIN SIZE; CANNABIS WITHDRAWAL SYMPTOM CHECKLIST; CLINICAL ARTICLE; CLINICAL ASSESSMENT TOOL; CORRELATION ANALYSIS; DRUG DEPENDENCE; DRUG WITHDRAWAL; FEMALE; HUMAN; MALE; MOOD; NEUROANATOMY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; SLEEP DISORDER; VOXEL BASED MORPHOMETRY; WITHDRAWAL SYNDROME; AMYGDALA; CANNABIS SMOKING; CRAVING; ORGAN SIZE; PATHOLOGY; PHYSIOLOGY; PSYCHOLOGY; YOUNG ADULT;

ADOLESCENT; AMYGDALA; CANNABIS; CRAVING; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MARIJUANA SMOKING; ORGAN SIZE; SUBSTANCE WITHDRAWAL SYNDROME; YOUNG ADULT;

EID: 84923336638     PISSN: 00952990     EISSN: 10979891     Source Type: Journal    
DOI: 10.3109/00952990.2014.966198     Document Type: Article

References (60)

1. Substance Abuse and Mental Health Services Administration. Results from the 2012 National Survey on Drug Use and Health: Summary of National Findings. Rockville, MD: Substance Abuse and Mental Health Services Administration, 2013.
2. Johnston LD, O'Malley PM, Bachman JG, Schulenberg JE. Monitoring the future national results on adolescent drug use: overview of key findings, 2008. Bethesda, MD: National Institute on Drug Abuse, 2009.
3. Chen K, Sheth AJ, Elliot DK, Eagerm A. Prevalence and correlates of past-year substance use, abuse, and dependence in a suburban community sample of high-school students. Addictive Behav 2004; 29:413-423.
4. Durston S, Hulshoff Pol HE, Casey BJ, Giedd JN, Buitelaar JK, van Engeland H. Anatomical MRI of the developing human brain: what have we learned? J Am Acad Child Adolesc Psychiatry 2001;40: 1012-1020.
5. Jernigan TL, Gamst AC. Changes in volume with age-consistency and interpretation of observed effects. Neurobiol Aging 2005;26: 1271-1274.
6. Huttenlocher PR, Dabholkar AS. Regional difference in synaptogenesis in human cerebral cortex. J Computat Neurol 1997;387: 167-178.
7. Gogtay N, Giedd JN, Lusk L, Hayashi KM, Greenstein D, Vaituzis AC, Nugent III TF, et al. Dynamic mapping of human cortical development during childhood through early adulthood. Proc Natl Acad Sci USA 2004;101:8174-8179.
8. Giedd JN, Vaituzis AD, Hamburger SD, Lange N, Rajapakse JC, Kaysen D, Vauss YC, Rapoport JL. Quantitative MRI of the temporal lobe, amygdala, and hippocampus in normal human development: ages 4-18 years. J Comparat Neurol 1996;366: 223-230.
9. Giedd JN, Castellanos FX, Rajapakse JC, Vaituzis AD, Rapoport JL. Sexual dimorphism of the developing human brain. Prog Neuropsychopharmacol Biolog Psychiatry 1997;21: 1185-1205.
10. Giedd JN. The teen brain: insights from neuroimaging. J Adolescent Health 2008;42:335-343.
11. Casey BJ, Galvan A, Getz S. The adolescent brain. Developmental Rev 2008;28:62-77.
12. Galvan A, Hare TA, Parra CE, Penn J, Voss H, Glover G, Casey BJ. Earlier development of the accumbens relative to orbitofrontal cortex might underlie risk-taking behavior in adolescents. J Neurosci 2006;26:688-6892.
13. Casey BJ, Jones RM, Hare TA. The storm and stress of adolescence: insights from human imaging and mouse genetics. Developmental Psychobiol 2010;52:225-235.
14. Lenroot RK, Giedd JN. Sex differences in the adolescent brain. Brain Cognit 2010;72:46-55.
15. Lisdahl KM, Gilbart ER, Wright NE, Shollenbarger S. Dare to delay? The impacts of adolescent alcohol and marijuana use onset on cognition, brain structure, and function. Front Psychiatry 2013;4:53.
16. Hare TA, Tottenham N, Galvan A, Voss HU, Glover GH, Casey BJ. Biological substrates of emotional reactivity and regulation in adolescence during an emotional go-nogo task. Biolog Psychiatry 2008;63:927-934.
17. Ashtari M, Cervellione K, Cottone J, Ardekani BA, Sevy S, Kumra S. Diffusion abnormalities in adolescents and young adults with a history of heavy cannabis use. J Psychiatric Res 2009;43: 189-204.
18. Bava S, Frank L, McQueeny T, Schweinsburg BC, Schweinsburg AD, Tapert SF. Altered white matter microstructure in adolescent substance users. Psychiatry Res 2009;173:228-237.
19. Medina KL, McQueeny T, Nagel BJ, Hanson KL, Yang T, Tapert SF. Prefrontal morphometry in abstinent adolescent marijuana users: subtle gender effects. Addiction Biol 2009;14: 457-468.
20. Medina KL, Schweinsburg AD, Cohen-Zion M, Nagel BJ, Tapert SF. Effects of alcohol and combined marijuana and alcohol use during adolescence on hippocampal asymmetry. Exposures during adolescent development: are neurotoxic risks increased? Neurotox Teratol 2007;29:141-152.
21. Medina KL, Nagel BJ, Tapert SF. Cerebellar vermis abnormality in adolescent marijuana users. Psychiatry Res 2010;182: 152-159.
22. McQueeny T, Padula CB, Price J, Medina KL, Logan P, Tapert SF. Gender effects on amygdala morphometry in adolescent marijuana users. Behav Brain Res 2011;224:128-134.
23. Schweinsburg AD, Schweinsburg BC, Cheung EH, Brown GG, Brown SA, Tapert SF. fMRI response to spatial working memory in adolescents with comorbid marijuana and alcohol use disorders. Drug Alcohol Depend 2005;79:201-210.
24. Padula CB, Schweinsburg AD, Tapert SF. Spatial working memory performance and fMRI activation interactions in abstinent adolescent marijuana users. Psychol Addictive Behav 2007;21: 478-487.
25. Harvey MA, Sellman JD, Porter RJ, Frampton CM. The relationship between non-acute adolescent cannabis use and cognition. Drug Alcohol Rev 2007;26:309-319.
26. Lane SD, Cherek DR, Tcheremissine OV, Steinberg JL, Sharon JL. Response perseveration and adaptation in heavy marijuana-smoking adolescents. Addictive Behav 2007;32:977-990.
27. Millsaps CL, Azrin RL, Mittenberg W. Neuropsychological effects of chronic cannabis use on the memory and intelligence of adolescents. J Child Adolesc Subst Abuse 1994;3:47-55.
28. Jacobsen LK, Mencl WE, Westerveld M, Pugh KR. Impact of cannabis use on brain function in adolescents. Ann NY Acad Sci 2004;1021:384-390.
29. Jager G, Block RI, Luijten M, Ramsey NF. Marijuana use and memory brain function in adolescent boys: a cross-sectional multicenter functional magnetic resonance imaging study. J Am Acad Child Adolescent Psychiatry 2010;49:561-572.
30. Jacobsen LK, Pugh KR, Constable RT, Westerveld M, Mencl WE. Functional correlates of verbal memory deficits emerging during nicotine withdrawal in abstinent adolescent cannabis users. Biolog Psychiatry 2007;61:31-40.
31. Tapert SF, Schweinsburg AD, Drummond SP, Paulus MP, Brown SA, Yang TT, Frank LR. Functional MRI of inhibitory processing in abstinent adolescent marijuana users. Psychopharmacology (Berlin) 2007;194:173-183.
32. Filbey FM, Schacht JP, Myers US, Chavez RS, Hutchison KE. Marijuana craving in the brain. Proc Natl Acad Sci USA 2009;106: 13016-13021.
33. Wrase J, Makris N, Braus DF, Mann K, Smolka MN, Kennedy DN, Caviness VS, et al. Amygdala volume associated with alcohol abuse relapse and craving. Am J Psychiatry 2008;165:1179-1184.
34. Makris N, Gasic GP, Seidmen L, Goldstein J, Gastfriend D, Albaugh DM, Hodge SM, et al. Decreased absolute amygdala volume in cocaine addicts. Neuron 2004;44:729-740.
35. Yucel M, Solowij N, Respondek C, Whittle S, Fornito A, Pantelis C, Lubman DI. Regional brain abnormalities associated with long-term heavy cannabis use. Arch Gen Psychiatry 2008;65: 694-701.
36. Fraser AD, Coffin L, Worth D. Drug and chemical metabolites in clinical toxicology investigations: The importance of ethylene glycol, methanol and cannabinoid metabolite analyses. Clinical Biochemistry 2002;35:501-511.
37. Smith ML, Barnes AJ, Huestis MA. Identifying new cannabis use with urine creatinine-normalized THCCOOH concentrations and time intervals between specimen collections. J Anal Toxicol 2009; 33:185-189.
38. Wechsler D. Manual for the Wechsler Abbreviated Scale of Intelligence. San Antonio, TX: The Psychological Corporation, 1999.
39. Brown SA, Myers MG, Lippke L, Tapert SF, Stewart DG, Vik PW. Psychometric evaluation of the Customary Drinking and Drug Use Record (CDDR): a measure of adolescent alcohol and drug involvement. J Stud Alcohol 1998;59:427-438.
40. Sobell LC, Sobell MB. Timeline follow-back: a technique for assessing self-reported alcohol consumption. In: Litten RZ, Allen JP, editors. Measuring alcohol consumption: psychosocial and biochemical methods. Totowa, NJ: Humana Press, 1992:41-72.
41. Budney AJ, Novy PL, Hughes JR. Marijuana withdrawal among adults seeking treatment for marijuana dependence. Addiction 1999;94:1311-1322.
42. Shaffer D, Fisher P, Lucas CP, Dulcan MK, Schwab-Stone ME. NIMH Diagnostic Interview Schedule for Children Version IV (NIMH DISC-IV): description, differences from previous versions, and reliability of some common diagnoses. J Am Acad Child Adolesc Psychiatry 2000;39:28-38.
43. Robins L, Cottler L, Bucholz K, Compton W. The Diagnostic Interview Schedule, Version 4.0. (DIS 4.0). St Louis, MO: Washington University, 1996.
44. Thompson LL, Riggs PD, Mikulich SK, Crowley TJ. Contribution of ADHD symptoms to substance problems and delinquency in conduct disordered adolescents. J Abnormal Child Psychol 1996; 24:325-347.
45. Beck AT. Beck depression inventory (BDI). San Antonio, TX: Psychological Corporation, 1978.
46. Bennett DS, Ambrosini PJ, Bianchi M, Barnett D, Metz C, Rabinovich H. Relationship of Beck Depression Inventory factors to depression among adolescents. J Affective Disord 1997;45: 127-134.
47. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol 1959;32:50-55.
48. Clark DB, Donovan JE. Reliability and validity of the Hamilton Anxiety Rating Scale in an adolescent sample. J Am Acad Child Adolesc Psychiatry 1994;33:354-360.
49. Zhang Y, Brady M, Smith S. Segmentation of brain MR images though a hidden random field model and the expectationmaximization algorithm. IEEE Trans Medical Imaging 2001;20: 45-57.
50. Cox RW. AFNI: software for analysis and visualization of functional magnetic resonance neuroimages. Computers Biomed Res 1996;29:162-173.
51. Richardson EJ, Griffith HR, Martin RC, Paige AL, Stewart CC, Jones J, Hermann BP, et al. Structural and functional neuroimaging correlates of depression in temporal lobe epilepsy. Epilepsy Behav 2007;10:242-249.
52. Sheline YL, Gado MH, Price JL. Amygdala core nuclei volumes are decreased in recurrent major depression. Neuroreport 1998;9: 2023-2028.
53. LeDoux J. The emotional brain, fear, and the amygdala. Cellular Molec Neurobiol 2003;23:727-738.
54. Pessoa L. On the relationship between emotion and cognition. Nature Rev 2008;9:148-158.
55. Phelps EA, LeDoux JE. Contributions of the amygdala to emotion processing: from animal models to human behavior. Neuron 2005; 48:175-187.
56. Marco EM, Rubino T, Adriana W, Viveros MP, Parolaro D, Laviola G. Long term consequences of URB597 administration during adolescence on cannabinoid CB1 receptor binding in brain areas. Brain Res 2009;1257:25-31.
57. Rubino T, Parolaro D. Long lasting consequences of cannabis exposure in adolescence. Molec Cellular Endocrinol 2008;286: 108-113.
58. Witkin JM, Tzavara ET, Nomikos GG. A role for cannabinoid CB1 receptors in mood and anxiety disorders. Behav Pharmacol 2005; 16:315-331.
59. Makris N, Oscar-Berman M, Jaffin SK, Hodge SM, Kennedy DN, Caviness VS, Marinkovic K, et al. Decreased volume of the brain reward system in alcohol. Biolog Psychiatry 2008;64: 192-202.
60. Becker JB, Hu M. Sex differences in drug abuse. Front Neuroendochrinol 2008;29:36-47.